Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

Presentation TCT 2016

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial

Presenter: Michael D. Dake, Kenneth Rosenfield, Costantino Del Giudice

November 01, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Daily News

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

Todd Neale

September 13, 2016

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

News Industry News

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

April 26, 2016

News Industry News

QT Vascular Announces The Allowance Of Four New Patents

July 15, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

Presentation TCT 2013

Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal Distribution and Reduction of Stent Edge Stenosis Progression in the Peripheral Swine Model

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Piotr Buszman, Yanping Cheng, Jong Shiuan Yeh, Gerard Conditt, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Vascular Injury Influences Drug Transfer and Vessel Healing Following Paclitaxel Coated Balloon Delivery in the Peripheral Arteries of Swine

Presenter: Maxwell Afari, Taylor Palmieri, Armando Tellez, Piotr Buszman, Krzysztof Milewski, Yanping Cheng, Seung-Jin Oh, Greg Kaluza, Juan Granada

January 31, 2013

Advertisement

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

QT Vascular Announces The Allowance Of Four New Patents

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal Distribution and Reduction of Stent Edge Stenosis Progression in the Peripheral Swine Model

Vascular Injury Influences Drug Transfer and Vessel Healing Following Paclitaxel Coated Balloon Delivery in the Peripheral Arteries of Swine

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content